Skip to main navigation
  • About Us
  • Programs
  • Join Us
  • Investors
  • Contact Us
Aerovate Therapeutics

Press Releases

Investors & Media

  •   Overview
  •   Press Releases
  •   Events & Presentations
  •   Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  •   Stock Information
    • Stock Quote & Chart
    • Investment Calculator
    • Historical Price Lookup
  •   Analyst Coverage
  •   Governance
    • Documents and Committee Composition
    • Leadership
    • Board of Directors
  •   Contact & FAQs
    • FAQs
    • Contact Us
    • Email Alerts

Stockholder Tools

  •   Print Page
  •   RSS Feeds
  •   Email Alerts
  •   Contact Us
May 16, 2022
Aerovate Therapeutics Presents Phase 1 Data for AV-101, A Novel Dry Powder Inhaled Formulation of Imatinib Being Developed for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH)
May 16, 2022
Aerovate Therapeutics Announces First Quarter 2022 Financial Results
March 30, 2022
Aerovate Therapeutics Announces Full-Year 2021 Financial Results
March 2, 2022
Aerovate Therapeutics to Present at Cowen 42nd Annual Health Care Conference
December 15, 2021
Aerovate Therapeutics Announces Initiation of IMPAHCT Phase 2b/Phase 3 Trial of AV-101 In Pulmonary Arterial Hypertension
November 15, 2021
Aerovate Therapeutics Announces Third Quarter 2021 Financial Results
September 17, 2021
Aerovate Therapeutics Announces Its Addition to the Russell 2000® Index
August 16, 2021
Aerovate Therapeutics Announces Second Quarter 2021 Financial Results
July 19, 2021
Aerovate Therapeutics Appoints Allison Dorval To Its Board of Directors
July 2, 2021
Aerovate Therapeutics Announces Closing of Initial Public Offering with Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 13

Investors & Media

  •   Overview
  •   Press Releases
  •   Events & Presentations
  •   Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  •   Stock Information
    • Stock Quote & Chart
    • Investment Calculator
    • Historical Price Lookup
  •   Analyst Coverage
  •   Governance
    • Documents and Committee Composition
    • Leadership
    • Board of Directors
  •   Contact & FAQs
    • FAQs
    • Contact Us
    • Email Alerts

Stockholder Tools

  •   Print Page
  •   RSS Feeds
  •   Email Alerts
  •   Contact Us
Aerovate Therapeutics
  • About Us
  • Programs
  • Join Us
  • Investors
  • Contact Us

© 2022 Aerovate Therapeutics, Inc. All Rights Reserved. | Privacy Policy | Terms of Use